2-Methylpiperazine structure
|
Common Name | 2-Methylpiperazine | ||
---|---|---|---|---|
CAS Number | 109-07-9 | Molecular Weight | 100.162 | |
Density | 0.8±0.1 g/cm3 | Boiling Point | 153.2±8.0 °C at 760 mmHg | |
Molecular Formula | C5H12N2 | Melting Point | 61-63 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 45.1±10.2 °C | |
Symbol |
GHS02, GHS07 |
Signal Word | Danger |
Name | 2-Methylpiperazine |
---|---|
Synonym | More Synonyms |
Density | 0.8±0.1 g/cm3 |
---|---|
Boiling Point | 153.2±8.0 °C at 760 mmHg |
Melting Point | 61-63 °C(lit.) |
Molecular Formula | C5H12N2 |
Molecular Weight | 100.162 |
Flash Point | 45.1±10.2 °C |
Exact Mass | 100.100044 |
PSA | 24.06000 |
LogP | -0.68 |
Vapour Pressure | 3.4±0.3 mmHg at 25°C |
Index of Refraction | 1.418 |
Storage condition | Flammables area |
Water Solubility | 78 g/100 mL (25 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS02, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H228-H315-H319-H335 |
Precautionary Statements | P210-P261-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | F:Flammable |
Risk Phrases | R11;R36/37/38 |
Safety Phrases | S16-S26-S36/37/39 |
RIDADR | UN 1325 4.1/PG 2 |
WGK Germany | 2 |
RTECS | TM1225020 |
Packaging Group | III |
Hazard Class | 4.1 |
HS Code | 2933599090 |
Precursor 9 | |
---|---|
DownStream 9 | |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Induction of human leukemia cell differentiation via PKC/MAPK pathways by arsantin, a sesquiterpene lactone from Artemisia santolina.
Arch. Pharm. Res. 38 , 2020-8, (2015) Sesquiterpene lactone compounds have received considerable attention in pharmacological research due to their therapeutic effects including anti-cancer and anti-inflammatory activities. In this report... |
2-methyl-piperazin |
Piperazine, 2-methyl- |
2-Methylpiperazine |
EINECS 203-644-2 |
Piperazine, 2-methyl-, (2S)- |
PIPERAZINE,2-METHYL- |
2-METHYLPIPERAZINE/LOMEFLOXCIN |
2-METHYLPIPERAZIN |
(rac)-2-methylpiperazine |
UNII:D0LWN1061P |
(S)-(+)-2-Methylpiperazine |
2-METHYLDIETHYLENEDIAMINE |
2-METHYL-PIPERAZINE |
2-methyl Piperazine |
(+/-)-2-METHYLPIPERAZINE |
2MPRZ |
(R,S)-2-methylpiperazine |
(2S)-2-Methylpiperazine |
(2R)-2-methylpiperazine |
MFCD00005954 |
2-METHYLPIPERAZINE FOR SYNTHESIS |
2-(R,S)-methylpiperazine |